Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 1-7

  Martinez E ^a   Sureda, A ^b   De Dalmases, C ^a   Sanchez J A ^a   Amill, B ^a   Tugues, D ^a   Sarda P ^b   Miralles, A ^a   Brunet, S ^b   Domingo Albos A ^b   Garcia J ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Autologous transplantation; Granulocyte macrophage colony stimulating factor; Multiple myeloma; Peripheral blood stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; CELL MOTILITY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPENIA; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 9544257290     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Barlogie B, Epstein J, Selvagayagam P, Alexanian R. Plasma cell myeloma: new biological insights and advances in therapy. Blood 1989; 73: 865-879.
2. Tura S, Cavo M, Baccaranni M et al. Bone marrow transplantation in multiple myeloma. Scand J Haematol 1986; 36: 176-179.
3. Barlogie B, Alexanian R, Dicke KA et al. High dose chemotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987; 70: 869-872.
4. Henon PH, Beck G, Deberck A et al. Autograft using peripheral blood stem cells collected after high dose melphalan in high risk multiple myeloma. Br J Haematol 1988; 70: 254-255.
5. Reiffers J, Marit G, Boiron JM. Peripheral blood stem cell transplantation in multiple myeloma. Br J Haematol 1989; 72: 296-297.
6. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
7. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-1039.
8. Stiff PJ, Murgo AJ, Wittes RE et al. Quantification of the peripheral blood colony for unit-cultures rise following chemotherapy: could leukapheresis replace bone marrow for autologous transplantation? Transfusion 1983; 23: 500-503.
9. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-585.
10. Siena S, Bregni M, Ravagnani F et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
11. Tarella C, Boccadoro M, Omede P et al. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant 1993; 11: 271-277.
12. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
13. Chronic Leukemia-Myeloma Task Force. Guidelines for protocol studies. Cancer Chemother Rep 1973; 4: 145-158.
14. Pike BL, Robinson WA. Human bone marrow colony growth in agar gel. J Cell Physiol 1970; 70: 77-84.
15. Gorin NC. Collection, manipulation and freeze-thawing of haemopoietic stem cells. Clin Haematol 1986; 15: 19-48.
16. Snedecor GW, Cochran WG. Statistical Methods. Iowa State University Press: Ames, Iowa, USA, 1979.
17. Kotasek D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collection following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11-17.
18. Ventura GJ, Barlogie B, Hester JP et al. High dose cyclophosphamide, BCNV and VP-16 with autologous blood stem cell support for refractory multiple myeloma. Bone Marrow Transplant 1990; 5: 265-268.
19. Badoux E, Beguin Y, Sautois B et al. Collection of peripheral blood stem cells from patients with malignant diseases: assessment by mononucleated count, CFU-GM/BFU-E assay and CD34 surface marker. Int J Cell Cloning 1992; 10 (Suppl. 1): 189.
20. Juttner CA, To LB, Haylock DN et al. Approaches to blood stem cell mobilization. Initial Australian clinical results. Bone Marrow Transplant 1990; 5: 22-24.
21. Gianni M. Where do we stand with respect to the use of peripheral blood progenitor cells? Ann Oncol 1994; 5: 781-784.
22. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma; identification of favorable variables for rapid engraftment in 255 patients. Blood 1995; 85: 588-596.
23. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.